HUP0301433A3 - Use of antiprogestins for producung pharmaceutical compositions for induction of apoptosis in a cell - Google Patents

Use of antiprogestins for producung pharmaceutical compositions for induction of apoptosis in a cell

Info

Publication number
HUP0301433A3
HUP0301433A3 HU0301433A HUP0301433A HUP0301433A3 HU P0301433 A3 HUP0301433 A3 HU P0301433A3 HU 0301433 A HU0301433 A HU 0301433A HU P0301433 A HUP0301433 A HU P0301433A HU P0301433 A3 HUP0301433 A3 HU P0301433A3
Authority
HU
Hungary
Prior art keywords
producung
antiprogestins
apoptosis
induction
cell
Prior art date
Application number
HU0301433A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HUP0301433A2 publication Critical patent/HUP0301433A2/hu
Publication of HUP0301433A3 publication Critical patent/HUP0301433A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0301433A 2000-10-18 2001-10-17 Use of antiprogestins for producung pharmaceutical compositions for induction of apoptosis in a cell HUP0301433A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24099100P 2000-10-18 2000-10-18
EP00250342 2000-10-18
PCT/EP2001/012006 WO2002032432A1 (en) 2000-10-18 2001-10-17 Use of antiprogestins for the induction of apoptosis in a cell

Publications (2)

Publication Number Publication Date
HUP0301433A2 HUP0301433A2 (hu) 2003-10-28
HUP0301433A3 true HUP0301433A3 (en) 2010-01-28

Family

ID=26072952

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301433A HUP0301433A3 (en) 2000-10-18 2001-10-17 Use of antiprogestins for producung pharmaceutical compositions for induction of apoptosis in a cell

Country Status (28)

Country Link
EP (1) EP1326617B9 (enExample)
JP (1) JP2004511523A (enExample)
KR (1) KR100668024B1 (enExample)
CN (1) CN1209111C (enExample)
AT (1) ATE334683T1 (enExample)
AU (2) AU2361902A (enExample)
BG (1) BG107744A (enExample)
BR (1) BR0114696A (enExample)
CA (1) CA2423020C (enExample)
CY (1) CY1105745T1 (enExample)
CZ (1) CZ299823B6 (enExample)
DE (1) DE60121980T2 (enExample)
DK (1) DK1326617T3 (enExample)
EA (1) EA010593B1 (enExample)
EE (1) EE200300157A (enExample)
ES (1) ES2269492T3 (enExample)
HR (1) HRP20030388A2 (enExample)
HU (1) HUP0301433A3 (enExample)
IL (2) IL154976A0 (enExample)
MX (1) MXPA03002955A (enExample)
NO (1) NO20031741L (enExample)
NZ (1) NZ538347A (enExample)
PL (1) PL360157A1 (enExample)
PT (1) PT1326617E (enExample)
SI (1) SI1326617T1 (enExample)
SK (1) SK4702003A3 (enExample)
UA (1) UA76729C2 (enExample)
WO (1) WO2002032432A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
CA2683517A1 (en) * 2007-04-23 2008-10-30 Bayer Schering Pharma Aktiengesellschaft Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
US20080268041A1 (en) * 2007-04-23 2008-10-30 Jens Hoffmann Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
CA2683809A1 (en) * 2007-04-23 2008-10-30 Bayer Schering Pharma Aktiengesellschaft Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
GB0718167D0 (en) 2007-09-18 2007-10-31 Cancer Rec Tech Ltd Cancer marker and therapeutic target
AU2012318618B2 (en) * 2011-10-04 2017-01-12 Invivis Pharmaceuticals Inc. Methods and systems for identifying and treating anti-progestin sensitive tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
UA76729C2 (uk) 2006-09-15
EE200300157A (et) 2003-08-15
JP2004511523A (ja) 2004-04-15
EA200300479A1 (ru) 2003-10-30
ATE334683T1 (de) 2006-08-15
KR100668024B1 (ko) 2007-01-15
NO20031741L (no) 2003-06-17
SK4702003A3 (en) 2004-01-08
EA010593B1 (ru) 2008-10-30
KR20030057540A (ko) 2003-07-04
MXPA03002955A (es) 2003-08-07
HRP20030388A2 (en) 2005-04-30
CA2423020A1 (en) 2002-04-25
EP1326617B9 (en) 2006-10-25
CA2423020C (en) 2009-01-20
AU2002223619B2 (en) 2006-08-24
SI1326617T1 (sl) 2007-02-28
DE60121980T2 (de) 2007-03-01
NO20031741D0 (no) 2003-04-15
BG107744A (bg) 2004-02-27
CN1469749A (zh) 2004-01-21
HK1062273A1 (en) 2004-10-29
IL154976A (en) 2007-05-15
CZ299823B6 (cs) 2008-12-03
AU2361902A (en) 2002-04-29
PT1326617E (pt) 2006-12-29
IL154976A0 (en) 2003-10-31
BR0114696A (pt) 2003-11-18
DE60121980D1 (de) 2006-09-14
ES2269492T3 (es) 2007-04-01
PL360157A1 (en) 2004-09-06
NZ538347A (en) 2007-03-30
WO2002032432A1 (en) 2002-04-25
HUP0301433A2 (hu) 2003-10-28
EP1326617B1 (en) 2006-08-02
CN1209111C (zh) 2005-07-06
CY1105745T1 (el) 2010-12-22
EP1326617A1 (en) 2003-07-16
DK1326617T3 (da) 2006-12-18

Similar Documents

Publication Publication Date Title
EG23943A (en) Flash-melt oral dosage formulation
EG24357A (en) New Pharmaceutical composition
HUP0202495A3 (en) Stable medicinal compositions for oral use
GB0009468D0 (en) Improvements in or relating to formulations for use in inhaler devices
HUP0302893A3 (en) Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
IL150447A0 (en) Pharmaceutical compositions containing entecavir
IL154012A0 (en) Hydrogel-driven drug dosage form
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0301042A3 (en) Pharmaceutical composition useful in contraception
HUP0302455A3 (en) Combination pharmaceutical compositions containing amplodipine and benazepril and their use
HUP0301713A3 (en) Pharmaceutical compositions containing propenone derivatives and their use
IL153487A0 (en) Pharmaceutical compositions and methods for use
IL153897A0 (en) Pharmaceutical compositions and methods for use
AU2003218261A8 (en) Improvements in pharmaceutical discovery and development
EP1210935A4 (en) DRUGS FOR ORAL USE
GB0005382D0 (en) Pharmaceutical composition
AU8254101A (en) Medicinal compositions
GB0022922D0 (en) Compounds for use in medicine
GB0015361D0 (en) Improvements in pharmaceutical compositions
GB0015360D0 (en) Improvements in pharmaceutical compositions
GB0124009D0 (en) Particles for use in a pharmaceutical composition
GB0014497D0 (en) Oral dosage form
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
IL134581A0 (en) Pharmaceutical dosage form

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees